|
|
||||||||
Abdominal Imaging |
1 Department of Radiology, University of California, San Francisco, 505
Parnassus Ave., San Francisco, CA 94143.
2 Department of Radiology, New York University Medical Center, 560 First Ave.,
TCHHW 202, New York, NY 10016.
3 Department of Medicine, Division of Gastroenterology, University of
California, San Francisco, San Francisco, CA 94143.
Received September 22, 2003; accepted after revision April 26, 2004.
Presented at the 2004 annual meeting of the American Roentgen Ray Society,
Miami Beach, FL.
OBJECTIVE. Our aim was to determine whether parallel imaging and diffusion tensor imaging affect the measurement of apparent diffusion coefficient (ADC) during diffusion-weighted MRI of the liver in healthy volunteers.
SUBJECTS AND METHODS. We performed breath-hold single-shot echo-planar diffusion-weighted MRI of the liver in 10 healthy volunteers using conventional diffusion, conventional diffusion with parallel imaging, and diffusion tensor with parallel imaging sequences. TE values for the three sequences were 83, 74, and 63, respectively. Liver signal intensity was measured on all sequences and normalized to the SD of the measurement. Hepatic ADC was calculated by acquiring all sequences with b values of 0 and 500 sec/mm2.
RESULTS. The normalized liver signal intensity was higher on diffusion tensor with parallel imaging and conventional diffusion with parallel imaging than on conventional diffusion without parallel imaging for a b value of 500 sec/mm2 (13.0 and 10.1 vs 9.1, respectively; p < 0.03) and for a b value of 0 sec/mm2 (9.0 and 7.6 vs 6.9, respectively; without reaching a significant difference, p = 0.12). Hepatic ADC was not significantly different between sequences (p = 0.16).
CONCLUSION. Higher signal intensity can be obtained when using parallel imaging and diffusion tensor imaging during diffusion-weighted MRI of the liver without compromising hepatic ADC measurement.
Results of several studies have suggested that measurement of hepatic apparent diffusion coefficient (ADC) by echo-planar diffusion-weighted MRI may be useful in the characterization of focal hepatic lesions (benign lesions have a higher ADC) and in the evaluation of diffuse liver disease (ADC is reduced in cirrhosis) [16]. However, single-shot echo-planar diffusion-weighted sequences of the liver are limited by poor signal-to-noise ratio, low spatial and contrast resolution, and relatively long TE values. The ideal TE value would approximate the T2 relaxation time of the liver parenchyma, (i.e., [mean ± SD] 46 ± 6 msec [7]), but most prior studies have used TE values of 70123. [2, 46].
Parallel imaging and diffusion tensor imaging are MRI sequences that allow the use of shorter TEs and might facilitate diffusion-weighted MRI of the liver. Parallel imaging is a technique that relies on the fact that the signal from a multielement surface coil contains limited spatial information because of the differing sensitivities of the component coils [8, 9]. Parallel imaging reduces the train of gradient echoes in combination with a faster k-space traversal per unit of time. The resultant increased bandwidth per pixel in the phase-encoding direction and the shortened echo-planar imaging train thus improve image quality. Diffusion tensor imaging uses additional gradients to plot the relative degree of diffusion in multiple dimensions and has been used predominantly in areas in which diffusion is preferentially restricted in one direction. The use of multiple diffusion gradient directions during diffusion tensor imaging allows gradient summation, resulting in stronger applied gradients and shorter TE values. To our knowledge, the measurement of hepatic ADC in either normal or abnormal livers using parallel imaging or diffusion tensor techniques has not been described. Therefore, we undertook this study to determine whether parallel imaging and diffusion tensor imaging affect the measurement of hepatic ADC during diffusion-weighted MRI of the liver in healthy volunteers.
Subjects and Methods
Subjects
This prospective single-institution study was approved by our institutional
committee on human research. Written informed consent was obtained from all
participants. We recruited 10 healthy adult volunteers between September 2002
and May 2003. To avoid the potentially confounding effects of alcoholic liver
disease and subsequent fatty infiltration, we did not recruit subjects with an
alcohol consumption of greater than 30 g per day for men or 15 g per day for
women [10]. The 10 healthy
volunteers consisted of seven men and three women with a mean age of 33 years
(range, 2744). None of the volunteers had a known history of acute or
chronic liver disease.
MRI Technique
MRI was performed on a 1.5-T superconducting body scanner (Intera, Philips
Medical Systems) equipped with high-performance gradients (maximum strength of
30 mT/m and maximum slew rate of 150 mT/m per millisecond). A four-element
quadrature phased-array surface coil was used to optimize signal- to-noise
ratio. Finger pulse triggering was used to decrease motion artifacts from
heart beating, as shown in a previous study
[11]. Conventional diffusion
without parallel imaging, conventional diffusion with parallel imaging, and
diffusion tensor with parallel imaging single-shot echo-planar
diffusion-weighted MRI sequences were performed in all subjects, using b
values of 0 and 500 sec/mm2. The selection of a b value of 500
sec/mm2 was based on a compromise between image quality and
adequate diffusion strength. Higher b values were found to produce
unacceptably low image signal. We used the following parameters: TR range of
1,8002,400; TEs of 83 (conventional diffusion), 74 (conventional
diffusion with parallel imaging), and 63 (diffusion tensor with parallel
imaging); echo-planar imaging factors of 69 (conventional diffusion), 33
(conventional diffusion with parallel imaging), and 39 (diffusion tensor with
parallel imaging); matrix of 128 x 83 (interpolated to 256 x 256);
1 signal acquired; field of view of 3640 cm; acquisition times (one or
more breath-holds as required) of 3640 sec (conventional diffusion),
3643 sec (conventional diffusion with parallel imaging), and
4360 sec (diffusion tensor with parallel imaging); and slice thickness
of 7 mm (15 slices acquired) with interslice gap of 2 mm. Parallel imaging was
performed using sensitivity encoding (SENSE, Philips Medical Systems). An
acceleration factor of 2 was used. The diffusion gradients were applied in
three orthogonal directions for conventional diffusion and conventional
diffusion with parallel imaging sequences (frequency-encoding [x],
phase-encoding [y], and section-select directions [z]) and
in six directions for diffusion tensor imaging with parallel imaging sequence
(x, y, z, xy, yz, xz).
In addition, for diffusion tensor imaging, we used a rotated frame of reference known as "Gradient overplus" (Philips Medical Systems) that resulted in greater gradient strength and shorter TE values. Frequency-selective fat saturation was used in all sequences to reduce chemical shift artifacts. No contrast medium was administered.
MRI Evaluation
A radiologist who was undertaking a fellowship in abdominal imaging
reviewed all images on a postprocessing workstation (Easy Vision Intera
workstation, release 8.1.3, Philips Medical Systems). Liver signal intensity
was recorded as the mean of values generated by placing three separate
circular regions of interest (ROIs) of 3-cm diameters over the right hepatic
lobe. Care was taken to exclude vessels from the ROIs. Because our version of
parallel imaging incorporated a filter that reduced background noise, we could
not directly measure the noise in each image. We calculated instead the
normalized signal intensity represented by the ratio of mean signal in a
homogeneous portion of the liver to the SD of signal over the ROI (the SD
representing both noise and tissue signal heterogeneity). For the same b value
and identical ROI, the signal heterogeneity should be constant, but the noise
component varies.
Hepatic ADC was calculated by solving the diffusion equation:
signal intensity for b = 500 sec/mm2 = (signal intensity for b = 0 sec/mm2) exp (b x ADC).
Statistical Analysis
Normalized signal intensity of the liver and hepatic ADCs as measured by
the three sequences for b values of 0 and 500 sec/mm2 were compared
using the nonparametric Kruskall-Wallis test for overall comparison and the
nonparametric Wilcoxon's signed rank test for paired comparisons when the
overall comparison was significant. A p value of less than 0.05 was
considered significant.
Results
Liver signal intensity, SD of signal intensity, and normalized signal intensity obtained with the three different diffusion-weighted sequences for b values of 0 and 500 sec/mm2 are shown in Table 1. When compared with a b value of 0 sec/mm2, there was an attenuation of liver signal with a b value of 500 sec/mm2. However, the normalized signal intensity (ratio of signal intensity to SD of signal intensity) is higher for a b value of 500 than for a b value of 0 and sec/mm2, in relationship to smaller SDs with b value of 500.
|
For a b value of 0 sec/mm2, higher normalized signal values were obtained with diffusion tensor with parallel imaging, followed by conventional diffusion with parallel imaging and conventional diffusion without parallel imaging; however, the difference was not significant (p = 0.12).
For b = 500 sec/mm2, there was a significant difference among the three sequences (p < 0.03): diffusion tensor with parallel imaging showed the highest signal intensity, followed by conventional diffusion with parallel imaging and by conventional diffusion without parallel imaging. In paired comparisons for a b value of 500 sec/mm2, the Wilcoxon's signed rank test showed no significant difference between conventional diffusion and conventional diffusion with parallel imaging (p = 0.57); however, there was a significant difference between conventional diffusion and diffusion tensor with parallel imaging and between conventional diffusion with parallel imaging and diffusion tensor with parallel imaging (p < 0.02 and p < 0.05, respectively). Hepatic ADCs were not significantly different among the three sequences (p = 0.16); values are shown in Table 2.
|
Images from a healthy volunteer are shown in Figures 1A, 1B, 1C, 1D, 1E, 1F, 1G, 1H, and 1I.
|
|
|
|
|
|
|
|
|
Discussion
Our preliminary results suggest that parallel imaging and diffusion tensor imaging can be combined to improve signal intensity during diffusion-weighted MRI of the liver, without compromising measurement of hepatic ADC, particularly after application of the diffusion gradients. The diffusion tensor imaging technique in conjunction with parallel imaging benefits from the shorter TEs as well as from additional sample points for generating the isotropic diffusion and ADC maps, with subsequent improvement in signal intensity. By decreasing the echo-train length, we found that parallel imaging reduces off-resonance and blurring artifacts related to echo-planar imaging [8, 9, 12, 13], although image quality was not analyzed as an end point in our study. Parallel imaging with diffusion tensor imaging could be used to increase matrix acquisition size [14], with subsequent better image qual ity. Potential applications include the evaluation of liver fibrosis in chronic hepatitis and better detection and characterization of focal liver lesions.
Our results are also consistent with recent studies on brain diffusion-weighted MRI that showed that conventional diffusion imaging with parallel imaging and diffusion tensor imaging with parallel imaging were of the same or better quality than conventional echo-planar sequences [9, 12, 13, 15]. In our study, improved image quality with parallel imaging occurred despite the theoretic decrease in signal-to-noise ratio using this technique [8, 12, 16].
We did not measure the signal-to-noise ratio, but we measured instead the normalized signal (ratio of signal intensity and SD of signal intensity). We think that the SD of signal intensity reflects both heterogeneity of tissues and noise. For the same b value and identical ROI, the signal heterogeneity should be constant but the noise component varies.
Described applications of parallel imaging include 3D contrast-enhanced angiography [17], real-time cardiac imaging [18], brain functional imaging [19], and multiphasic dynamic-enhanced abdominal imaging [20].
Our study highlights the potential for the novel combination of parallel imaging and diffusion tensor imaging during diffusion-weighted MRI of the liver. To date, diffusion tensor imaging has been used predominantly for brain imaging, particularly fiber tractography [2124]. Only one study has described the use of diffusion tensor imaging in the abdomen for evaluation of the kidneys in healthy volunteers [25]. We found that the combination of parallel imaging and diffusion tensor imaging maximized the advantageous reduction in TEs, despite the slightly longer acquisition time related to the multiple diffusion gradient directions. We found no difference in the measurement of hepatic ADC among the sequences investigated. Although we obtained higher ADC values for normal liver (1.511.60 x 103 mm2/sec) than those reported in a recent study (0.921.14 x 103 mm2/sec) [11], the difference may be related to the lower b value that we used (500 vs 1,300 sec/mm2).
Our study has some limitations. Only a small number of subjects were studied. We did not evaluate fractional anisotropy on diffusion tensor imaging, although this evaluation is unlikely to have been helpful because a previous study showed that normal liver has isotropic diffusion [6]. As with other studies, we found measurement of ADC to have a relatively large SD. More precise techniques for ADC measurement would be desirable. We did not investigate the role of different b values because a previous study showed satisfactory results with a b value of 500 sec/mm2 [6] and because higher b values are associated with a greater reduction in signal and lower image quality.
In conclusion, diffusion tensor imaging and parallel imaging can be used to increase signal intensity during diffusion-weighted MRI of the liver without compromising the measurement of hepatic ADC.
References
This article has been cited by other articles:
![]() |
L. Mannelli, S. Kim, C. H. Hajdu, J. S. Babb, T. W. I. Clark, and B. Taouli Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted Liver Am. J. Roentgenol., October 1, 2009; 193(4): 1044 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Faria, K. Ganesan, I. Mwangi, M. Shiehmorteza, B. Viamonte, S. Mazhar, M. Peterson, Y. Kono, C. Santillan, G. Casola, et al. MR Imaging of Liver Fibrosis: Current State of the Art RadioGraphics, October 1, 2009; 29(6): 1615 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Saremi, A. N. Knoll, O. J. Bendavid, H. Schultze-Haakh, N. Narula, and F. Sarlati Characterization of Genitourinary Lesions with Diffusion-weighted Imaging RadioGraphics, September 1, 2009; 29(5): 1295 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Low, C. P. Sebrechts, R. M. Barone, and W. Muller Diffusion-Weighted MRI of Peritoneal Tumors: Comparison With Conventional MRI and Surgical and Histopathologic Findings--A Feasibility Study Am. J. Roentgenol., August 1, 2009; 193(2): 461 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Taouli, R. L. Ehman, and S. B. Reeder Advanced MRI Methods for Assessment of Chronic Liver Disease Am. J. Roentgenol., July 1, 2009; 193(1): 14 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kandpal, R. Sharma, K. S. Madhusudhan, and K. S. Kapoor Respiratory-Triggered Versus Breath-Hold Diffusion-Weighted MRI of Liver Lesions: Comparison of Image Quality and Apparent Diffusion Coefficient Values Am. J. Roentgenol., April 1, 2009; 192(4): 915 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Braithwaite, B. M. Dale, D. T. Boll, and E. M. Merkle Short- and Midterm Reproducibility of Apparent Diffusion Coefficient Measurements at 3.0-T Diffusion-weighted Imaging of the Abdomen Radiology, February 1, 2009; 250(2): 459 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
T NIWA, M UENO, S OHKAWA, T YOSHIDA, T DOIUCHI, K ITO, and T INOUE Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy Br. J. Radiol., January 1, 2009; 82(973): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Luciani, A. Vignaud, M. Cavet, J. Tran Van Nhieu, A. Mallat, L. Ruel, A. Laurent, J.-F. Deux, P. Brugieres, and A. Rahmouni Liver Cirrhosis: Intravoxel Incoherent Motion MR Imaging--Pilot Study Radiology, December 1, 2008; 249(3): 891 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bruegel, J. Gaa, S. Waldt, K. Woertler, K. Holzapfel, B. Kiefer, and E. J. Rummeny Diagnosis of Hepatic Metastasis: Comparison of Respiration-Triggered Diffusion-Weighted Echo-Planar MRI and Five T2-Weighted Turbo Spin-Echo Sequences Am. J. Roentgenol., November 1, 2008; 191(5): 1421 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Parikh, S. J. Drew, V. S. Lee, S. Wong, E. M. Hecht, J. S. Babb, and B. Taouli Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging Radiology, March 1, 2008; 246(3): 812 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Taouli, A. J. Tolia, M. Losada, J. S. Babb, E. S. Chan, M. A. Bannan, and H. Tobias Diffusion-Weighted MRI for Quantification of Liver Fibrosis: Preliminary Experience Am. J. Roentgenol., October 1, 2007; 189(4): 799 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Coenegrachts, J Delanote, L Ter Beek, M Haspeslagh, S Bipat, J Stoker, F Van Kerkhove, L Steyaert, H Rigauts, and J W Casselman Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques Br. J. Radiol., July 1, 2007; 80(955): 524 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-M. Koh and D. J. Collins Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology Am. J. Roentgenol., June 1, 2007; 188(6): 1622 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-M. Koh, E. Scurr, D. Collins, B. Kanber, A. Norman, M. O. Leach, and J. E. Husband Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients Am. J. Roentgenol., April 1, 2007; 188(4): 1001 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, H. Kawamitsu, D. G. Mitchell, Y. Ohno, Y. Ku, Y. Seo, M. Fujii, and K. Sugimura ADC measurement of abdominal organs and lesions using parallel imaging technique. Am. J. Roentgenol., December 1, 2006; 187(6): 1521 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Vandecaveye, F de Keyzer, V Vander Poorten, K Deraedt, H Alaerts, W Landuyt, S Nuyts, and R Hermans Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases Br. J. Radiol., August 1, 2006; 79(944): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Lee Science to Practice: Can MR Imaging Replace Liver Biopsy for the Diagnosis of Early Fibrosis? Radiology, May 1, 2006; 239(2): 309 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, X. Sun, F. De Keyzer, J. Yu, R. Peeters, W. Coudyzer, V. Vandecaveye, W. Landuyt, H. Bosmans, P. Van Hecke, et al. Liver Tumor Model with Implanted Rhabdomyosarcoma in Rats: MR Imaging, Microangiography, and Histopathologic Analysis Radiology, May 1, 2006; 239(2): 554 - 562. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |